W

02496

Wuhan YZY Biopharma

2.500

+0.295+13.38%
Closed15:59 10/09 HKT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE--/2.900
TODAY RANGE-
VOL2.29M
MARKET CAP678.47M
52 WEEK RANGE2.200-8.400
AVG VOL (3M)163.91K
% TURNOVER1.18%
TURNOVER6.17M
P/E (TTM)-18.325
% RANGE--
EPS(TTM)-0.191
P/E(FORWARD)--
P/B-10.063
BVPS-0.348
DIVIDEND--
P/S9.381
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP628.18M
SHARES OUTSTANDING193.85M
NEXT EARNINGS--
FREE FLOAT179.48M
LOT SIZE200
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

昊

昊海生物科技

06826

+0.25%
16.110

藥

藥明康德

02359

-0.48%
208.000

泰

泰格醫藥

03347

+0.77%
44.560

昭

昭衍新藥

06127

+4.12%
31.320

康

康龍化成

03759

-2.11%
30.600

F

Frontage Holdings

01521

-4.74%
1.105

01035

--

中

中國醫療集團

08225

0.00%
0.079

銘

銘源醫療

00233

0.00%
0.230

08572

--

邁

邁博藥業-B

02181

+1.00%
0.505

維

維亞生物

01873

+1.31%
1.545

C

China Regenerative Medicine International

08158

0.00%
0.310

東

東曜藥業-B

01875

-0.56%
3.560

H

Hua Medicine

02552

-2.69%
2.170

微

微創腦科學

02172

0.00%
8.055

康

康寧傑瑞製藥-B

09966

-2.45%
7.355

中

中國抗體-B

03681

+7.48%
1.150

樂

樂普生物

02157

-0.65%
3.820

加

加科思-B

01167

-4.30%
5.570

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.